Diabetes Mellitus as a Risk Factor for Parkinson’s Disease: a Molecular Point of View
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes Mellitus as a Risk Factor for Parkinson’s Disease: a Molecular Point of View
Authors
Keywords
α-Synuclein, Type 2 diabetes mellitus, Dopamine, DOPAL, Methylglyoxal, Parkinson’s disease
Journal
MOLECULAR NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-03-28
DOI
10.1007/s12035-018-1025-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impaired peripheral glucose homeostasis and Alzheimer's disease
- (2018) Nadeeja Wijesekara et al. NEUROPHARMACOLOGY
- Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
- (2018) Marcelo N.N. Vieira et al. NEUROPHARMACOLOGY
- Type 2 diabetes
- (2017) Sudesna Chatterjee et al. LANCET
- Increased risk of Parkinson disease with diabetes mellitus in a population-based study
- (2017) Yu-Wan Yang et al. MEDICINE
- Selective neuronal vulnerability in Parkinson disease
- (2017) D. James Surmeier et al. NATURE REVIEWS NEUROSCIENCE
- Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease
- (2017) Nikita Katila et al. NEUROPHARMACOLOGY
- Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
- (2017) Fabio A. Zucca et al. PROGRESS IN NEUROBIOLOGY
- Guanine glycation repair by DJ-1/Park7 and its bacterial homologs
- (2017) Gilbert Richarme et al. SCIENCE
- DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
- (2017) N. Plotegher et al. Scientific Reports
- Lysines, Achilles’ heel in alpha-synuclein conversion to a deadly neuronal endotoxin
- (2016) Nicoletta Plotegher et al. AGEING RESEARCH REVIEWS
- Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies
- (2016) Yousif A. Shamsaldeen et al. CURRENT DRUG METABOLISM
- Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation
- (2016) Mingzhan Xue et al. DIABETES
- Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics
- (2016) Naila Rabbani et al. GLYCOCONJUGATE JOURNAL
- Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson’s Disease via Autophagy and Mitochondrial ROS Clearance
- (2016) Ming Lu et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance
- (2016) Dena G. Hernandez et al. JOURNAL OF NEUROCHEMISTRY
- Risk of Parkinson Disease in Diabetes Mellitus
- (2016) Xuejing Yue et al. MEDICINE
- Metformin Prevents Nigrostriatal Dopamine Degeneration Independent of AMPK Activation in Dopamine Neurons
- (2016) Jacqueline A. Bayliss et al. PLoS One
- Dicarbonyl stress in cell and tissue dysfunction contributing to ageing and disease
- (2015) Naila Rabbani et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)
- (2015) Cristian Follmer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of type 2 diabetes in neurodegeneration
- (2015) Giuseppe Verdile et al. NEUROBIOLOGY OF DISEASE
- Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
- (2014) Marco Bisaglia et al. AGEING RESEARCH REVIEWS
- Metformin: From Mechanisms of Action to Therapies
- (2014) Marc Foretz et al. Cell Metabolism
- Benomyl, Aldehyde Dehydrogenase, DOPAL, and the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson’s Disease
- (2014) John E. Casida et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Parkinsonism-associated Protein DJ-1/Park7 Is a Major Protein Deglycase That Repairs Methylglyoxal- and Glyoxal-glycated Cysteine, Arginine, and Lysine Residues
- (2014) Gilbert Richarme et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samples
- (2014) Naila Rabbani et al. Nature Protocols
- Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice
- (2014) S.P. Patil et al. NEUROSCIENCE
- Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein
- (2014) Yunden Jinsmaa et al. NEUROSCIENCE LETTERS
- Biophysical groundwork as a hinge to unravel the biology of α-synuclein aggregation and toxicity
- (2014) Nicoletta Plotegher et al. QUARTERLY REVIEWS OF BIOPHYSICS
- Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
- (2014) B. G. Wilhelm et al. SCIENCE
- DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson’s disease
- (2014) L Zondler et al. Cell Death & Disease
- Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes
- (2013) Paul Voziyan et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- The Critical Role of Methylglyoxal and Glyoxalase 1 in Diabetic Nephropathy
- (2013) N. Rabbani et al. DIABETES
- Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies
- (2013) Marco Bisaglia et al. FASEB JOURNAL
- Neuronal vulnerability, pathogenesis, and Parkinson's disease
- (2013) David Sulzer et al. MOVEMENT DISORDERS
- Shared dysregulated pathways lead to Parkinson's disease and diabetes
- (2013) Jose A. Santiago et al. TRENDS IN MOLECULAR MEDICINE
- Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions
- (2013) Geert Jan Biessels et al. Lancet Diabetes & Endocrinology
- Risk of Parkinson Disease Onset in Patients With Diabetes: A 9-year population-based cohort study with age and sex stratifications
- (2012) Y. Sun et al. DIABETES CARE
- Human DJ-1 and its homologs are novel glyoxalases
- (2012) Ju-young Lee et al. HUMAN MOLECULAR GENETICS
- Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 and Cys-53
- (2012) Stefania Girotto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?
- (2012) Elisa Greggio et al. Journal of Neuroinflammation
- Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort
- (2012) Mark L. Wahlqvist et al. PARKINSONISM & RELATED DISORDERS
- Neurodegeneration and Motor Dysfunction in Mice Lacking Cytosolic and Mitochondrial Aldehyde Dehydrogenases: Implications for Parkinson's Disease
- (2012) Margaret Chia-Ying Wey et al. PLoS One
- Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
- (2012) A. G. Fitzmaurice et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycation
- (2011) Mingzhan Xue et al. BIOCHEMICAL JOURNAL
- Diabetes and the Risk of Developing Parkinson's Disease in Denmark
- (2011) E. Schernhammer et al. DIABETES CARE
- Diabetes and Risk of Parkinson's Disease
- (2011) Q. Xu et al. DIABETES CARE
- AMP-activated protein kinase--an energy sensor that regulates all aspects of cell function
- (2011) D. G. Hardie GENES & DEVELOPMENT
- Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome
- (2010) Naila Rabbani et al. AMINO ACIDS
- Dopamine quinones interact with α-synuclein to form unstructured adducts
- (2010) Marco Bisaglia et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: Implications for mitochondrial dysfunction in Parkinson disease
- (2010) Marco Bisaglia et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy
- (2010) Jianxin Lu et al. CLINICAL BIOCHEMISTRY
- Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the Catechol
- (2009) Jennifer N. Rees et al. CHEMICAL RESEARCH IN TOXICOLOGY
- AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
- (2009) Carles Cantó et al. NATURE
- Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons
- (2009) Eugene V. Mosharov et al. NEURON
- Dopamine-Induced Conformational Changes in Alpha-Synuclein
- (2009) Tiago F. Outeiro et al. PLoS One
- Structural insights on physiological functions and pathological effects of α-synuclein
- (2008) Marco Bisaglia et al. FASEB JOURNAL
- Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and Autostimulation
- (2008) Marianne Böni-Schnetzler et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis
- (2008) Claire Henchcliffe et al. Nature clinical practice. Neurology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now